United Therapeutics has paid $140 million to buy Thymmune Therapeutics for preclinical regenerative cell therapies focused on the thymus.

In a study published in Signal Transduction and Targeted Therapy, the researchers used MIR2911, a plant microRNA enriched in honeysuckle, as a proof-of-concept example.

Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in western ...

Utilizing SERS for protein detection offers high sensitivity and label-free analysis, advancing proteomics and biomarker ...